Hormones in Neuroscience: The Pancreas and Pancreatic Hormones explores the latest research in neuroendocrinology in relation to the pancreas and pancreatic hormones. This volume aims to cover the deficiencies in existing literature on the link between hormones and neurological tissues. This book offers a translational context and seeks to address the behavioral consequences of altered endocrine gland pathology while also addressing causative and modulating influences.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Disclaimer - p. xix 7. Contributors - p. xxi 8. Preface - p. xxv 9. Section 1. Introductory chapters - p. S1 10. Chapter 1. Pancreatic hormones: a focus on amylin—a new narrative - p. 3 11. Chapter 2. Computational modeling of the pancreas and pancreatic function - p. 13 12. Chapter 3. Pancreatic hormones and the gut-brain axis - p. 25 13. Chapter 4. Somatostatin: A crossroad between pancreatic and neural pathways - p. 41 14. Chapter 5. Feeding and fasting and impact on pancreatic hormones: insulin and beyond - p. 55 15. Section 2. Focused areas of neurological pathology and physiology - p. S2 16. Chapter 6. Type 2 diabetes and the increased risk of dementia - p. 73 17. Chapter 7. The interstitial fluid dynamics and diabetes mellitus - p. 87 18. Chapter 8. Brain insulin receptor gene networks, behavior and disease risk over the life course - p. 95 19. Chapter 9. Linking exosomes and neuropathy in diabetics conditions - p. 109 20. Chapter 10. The divalent metal transporter 1 (DMT1), neuroprotection and insulin - p. 121 21. Chapter 11. Peripheral nerves in diabetic neuropathy: Features and methods - p. 129 22. Chapter 12. Linking brain insulin receptors, neural stem cells and synaptic plasticity: Potential implications for neurodegenerative disorders - p. 143 23. Section 3. Psychology and behavior as a consequence of changes in the pancreas or the pancreatic endocrine status or the effects of hormones - p. S3 24. Chapter 13. Cognitive links with brain insulin signaling in metabolism: A new narrative - p. 159 25. Chapter 14. Insulin-linked synaptic modulation in Alzheimer's pathology: Emerging potential of nanofibers - p. 174 26. Chapter 15. Sexual dysfunction and mood symptoms in patients with diabetes - p. 189 27. Chapter 16. Anxiety related behavior in parents of diabetic children - p. 205 28. Chapter 17. Insulin signaling and impairments in executive functions in preclinical models: A narrative approach - p. 217 29. Section 4. Treatment regimens modulating pancreatic hormones status and impact on neurological tissues and behavior - p. S4 30. Chapter 18. Drugs used in treating diabetes and insulin resistance: Neurological and behavioral effects - p. 233 31. Chapter 19. Insulin treatments and effects on neurotransmitters - p. 247 32. Chapter 20. Pancreas and pancreatic hormones: Insulin dosing behavior and “insulin metrics” - p. 257 33. Chapter 21. Metformin treatment and effects on psychiatric behaviors: Measures of depression - p. 269 34. Chapter 22. Psychotherapeutic interventions in diabetes care: A narrative review and conceptual framework of CBT and beyond - p. 279 35. Chapter 23. Modulation of oxidative stress in the management of pancreatitis - p. 289 36. Chapter 24. Diabetic complications with emphasis on neuropathy: Mechanistic insights and therapeutic role of aldose reductase inhibitors - p. 301 37. Chapter 25. Phytomedicine in diabetes care: Molecular pathways and therapeutic mechanisms - p. 313 38. Chapter 26. Hypothalamic neurons and treatment with metformin and propionate - p. 325 39. Section 5. Nonpancreatic treatment regimens and effects on neuroscientific domains - p. S5 40. Chapter 27. Statins and insulin resistance - p. 341 41. Chapter 28. Linking mitochondrial integrity and insulin resistance in response to pharmacological agents - p. 353 42. Chapter 29. Insulin secretion and effects of beta-adrenergic blockers - p. 365 43. Chapter 30. Focused review: Clozapine safety and effects on pancreatitis - p. 377 44. Section 6. Diseases of the pancreas or pancreas hormones status and impact on the brain and behavior - p. S6 45. Chapter 31. Pancreatic cancer—An overview - p. 391 46. Chapter 32. Acute pancreatitis and its impact on mental health - p. 407 47. Section 7. Diet and nutrition and impact on the pancreas and neuroscientific domains or behavior - p. S7 48. Chapter 33. Diet, diabetes and gene expression in the brain - p. 423 49. Chapter 34. Diet, behavior and diabetes—an overview - p. 433 50. Chapter 35. Brain insulin signaling and nutritional modulation: the role of microRNAs and the gut–brain axis - p. 445 51. Chapter 36. Vitamins, analog and effects on insulin signaling in the brain - p. 461 52. Chapter 37. Recommended resources for the study of hormones in neuroscience: The Pancreas and Pancreatic Hormones - p. 473 53. Index - p. 483
Hormones in Neuroscience: The Pancreas and Pancreatic Hormones explores the latest research in neuroendocrinology in relation to the pancreas and pancreatic hormones. This volume aims to cover the deficiencies in existing literature on the link between hormones and neurological tissues. This book offers a translational context and seeks to address the behavioral consequences of altered endocrine gland pathology while also addressing causative and modulating influences.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Disclaimer - p. xix 7. Contributors - p. xxi 8. Preface - p. xxv 9. Section 1. Introductory chapters - p. S1 10. Chapter 1. Pancreatic hormones: a focus on amylin—a new narrative - p. 3 11. Chapter 2. Computational modeling of the pancreas and pancreatic function - p. 13 12. Chapter 3. Pancreatic hormones and the gut-brain axis - p. 25 13. Chapter 4. Somatostatin: A crossroad between pancreatic and neural pathways - p. 41 14. Chapter 5. Feeding and fasting and impact on pancreatic hormones: insulin and beyond - p. 55 15. Section 2. Focused areas of neurological pathology and physiology - p. S2 16. Chapter 6. Type 2 diabetes and the increased risk of dementia - p. 73 17. Chapter 7. The interstitial fluid dynamics and diabetes mellitus - p. 87 18. Chapter 8. Brain insulin receptor gene networks, behavior and disease risk over the life course - p. 95 19. Chapter 9. Linking exosomes and neuropathy in diabetics conditions - p. 109 20. Chapter 10. The divalent metal transporter 1 (DMT1), neuroprotection and insulin - p. 121 21. Chapter 11. Peripheral nerves in diabetic neuropathy: Features and methods - p. 129 22. Chapter 12. Linking brain insulin receptors, neural stem cells and synaptic plasticity: Potential implications for neurodegenerative disorders - p. 143 23. Section 3. Psychology and behavior as a consequence of changes in the pancreas or the pancreatic endocrine status or the effects of hormones - p. S3 24. Chapter 13. Cognitive links with brain insulin signaling in metabolism: A new narrative - p. 159 25. Chapter 14. Insulin-linked synaptic modulation in Alzheimer's pathology: Emerging potential of nanofibers - p. 174 26. Chapter 15. Sexual dysfunction and mood symptoms in patients with diabetes - p. 189 27. Chapter 16. Anxiety related behavior in parents of diabetic children - p. 205 28. Chapter 17. Insulin signaling and impairments in executive functions in preclinical models: A narrative approach - p. 217 29. Section 4. Treatment regimens modulating pancreatic hormones status and impact on neurological tissues and behavior - p. S4 30. Chapter 18. Drugs used in treating diabetes and insulin resistance: Neurological and behavioral effects - p. 233 31. Chapter 19. Insulin treatments and effects on neurotransmitters - p. 247 32. Chapter 20. Pancreas and pancreatic hormones: Insulin dosing behavior and “insulin metrics” - p. 257 33. Chapter 21. Metformin treatment and effects on psychiatric behaviors: Measures of depression - p. 269 34. Chapter 22. Psychotherapeutic interventions in diabetes care: A narrative review and conceptual framework of CBT and beyond - p. 279 35. Chapter 23. Modulation of oxidative stress in the management of pancreatitis - p. 289 36. Chapter 24. Diabetic complications with emphasis on neuropathy: Mechanistic insights and therapeutic role of aldose reductase inhibitors - p. 301 37. Chapter 25. Phytomedicine in diabetes care: Molecular pathways and therapeutic mechanisms - p. 313 38. Chapter 26. Hypothalamic neurons and treatment with metformin and propionate - p. 325 39. Section 5. Nonpancreatic treatment regimens and effects on neuroscientific domains - p. S5 40. Chapter 27. Statins and insulin resistance - p. 341 41. Chapter 28. Linking mitochondrial integrity and insulin resistance in response to pharmacological agents - p. 353 42. Chapter 29. Insulin secretion and effects of beta-adrenergic blockers - p. 365 43. Chapter 30. Focused review: Clozapine safety and effects on pancreatitis - p. 377 44. Section 6. Diseases of the pancreas or pancreas hormones status and impact on the brain and behavior - p. S6 45. Chapter 31. Pancreatic cancer—An overview - p. 391 46. Chapter 32. Acute pancreatitis and its impact on mental health - p. 407 47. Section 7. Diet and nutrition and impact on the pancreas and neuroscientific domains or behavior - p. S7 48. Chapter 33. Diet, diabetes and gene expression in the brain - p. 423 49. Chapter 34. Diet, behavior and diabetes—an overview - p. 433 50. Chapter 35. Brain insulin signaling and nutritional modulation: the role of microRNAs and the gut–brain axis - p. 445 51. Chapter 36. Vitamins, analog and effects on insulin signaling in the brain - p. 461 52. Chapter 37. Recommended resources for the study of hormones in neuroscience: The Pancreas and Pancreatic Hormones - p. 473 53. Index - p. 483
